Matinas Biopharma (MTNB) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Matinas Biopharma is the larger company by market cap ($2.8 million vs $2.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MTNB | TCRT |
|---|---|---|
| Share price | $2.83 | $0.781 |
| Market cap | $2.77M | $2.29M |
| 1-day change | +2.17% | -6.70% |
| EPS (TTM) | $-17.55 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.95 | $4.50 |
| 52-week low | $2.27 | $0.72 |
| Distance from 52-week high | -90.22% | -82.64% |
| Average volume | 408.10K | 797.20K |
| Shares outstanding | 979.52K | 2.93M |
| Employees | 2 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Healthcare · Biotechnology · 2 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Healthcare · Biotechnology · 1 employees
MTNB vs TCRT FAQ
Which is bigger, Matinas Biopharma or Alaunos Therapeutics?
Matinas Biopharma (MTNB) is larger, with a market capitalization of $2.77M compared with $2.29M for Alaunos Therapeutics (TCRT).
Are Matinas Biopharma and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.